» Articles » PMID: 39064555

Same Organ, Two Cancers: Complete Analysis of Renal Cell Carcinomas and Upper Tract Urothelial Carcinomas

Abstract

: Renal cell carcinomas and upper tract urothelial carcinomas are types of malignancies that originate in the kidneys. Each of these examples shows an increasing trend in the frequency and the mortality rate. This study aims to comprehensively define carcinomas by analyzing clinical, paraclinical, and histological aspects to predict aggressiveness and mortality. : We conducted a retrospective investigation on a group of patients suspected of kidney cancers. : We identified 188 cases. We observed a higher mortality rate and older age in individuals with urothelial carcinomas. Anemia, acute kidney injury, hematuria, and perineural invasion were the main risk factors that predicted their mortality. Tumor size in renal cell carcinomas correlates with the presence of necrosis and sarcomatoid areas. Factors that indicate a higher rate of death are older age, exceeding the renal capsule, a lesion that includes the entire kidney, lymphovascular invasion, acute kidney injury, and anemia. : Even if they originate at the renal level, and the clinical-paraclinical picture is similar, the histopathological characteristics make the difference. In addition, to these are added the previously mentioned common parameters that can represent important prognostic factors. In conclusion, the characteristics commonly identified in one type of cancer may act as risk factors for the other tumor. The detected data include threshold values and risk factors, making a significant contribution to the existing literature.

References
1.
Cassell 3rd A, Manobah B, Willie S . Diagnostic and Therapeutic Challenges of Rare Urogenital Cancers: Urothelial Carcinoma of the Renal Pelvis, Ureters and Urethra. World J Oncol. 2021; 12(1):20-27. PMC: 7935619. DOI: 10.14740/wjon1360. View

2.
Kryvenko O . Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: A study of 842 consecutive cases from a single institution. Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, Magi-Galluzzi C,.... Urol Oncol. 2017; 35(6):454-455. DOI: 10.1016/j.urolonc.2017.03.023. View

3.
Kim S, Campbell S, Gill I, Lane B, van Poppel H, Smaldone M . Collaborative Review of Risk Benefit Trade-offs Between Partial and Radical Nephrectomy in the Management of Anatomically Complex Renal Masses. Eur Urol. 2016; 72(1):64-75. DOI: 10.1016/j.eururo.2016.11.038. View

4.
Avulova S, Cheville J, Lohse C, Gupta S, Potretzke T, Tsivian M . Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol. 2020; 79(2):225-231. DOI: 10.1016/j.eururo.2020.10.007. View

5.
Miricescu D, Balan D, Tulin A, Stiru O, Vacaroiu I, Mihai D . PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (Review). Exp Ther Med. 2021; 21(5):540. PMC: 8014975. DOI: 10.3892/etm.2021.9972. View